The Mayo Clinic College of Medicine in Rochester, Minnesota is sending Debabrata Mukhopadhyay, Professor of Biochemistry and Molecular Biology, and Biomedical Engineering, to report on his findings at nanoTX’07.
“The use of nanotechnology in biology has grown over recent years, incorporating the use of reagents such as nanoparticles to directly deliver bioconjugates or nanoparticles that can be utilized as biomolecules as well,” advance notes on Mukhopadhyay’s speech summary say. “Our research suggests that gold nanoparticles are antiangiogenic molecules, whereas some of the lanthanide nanorods are proangiogenic. Overall, our goal is to develop the next generation of nanomedicines that can be translated to the clinics in the near future.”
Mukhopadhyay will report how near that future is early on October 4 at the Dallas Convention Center. All interested professionals can check the schedule and/or register at the web site, www.nanotx.biz
About nanoTX
nanoTX, presented this year by SIA, is the world’s most comprehensive nanotechnology conference and exposition. The event highlights advances in nanoscience, explains how nanotechnology is being used today and how it will impact a broad range of industries tomorrow, including: electronics, energy, aerospace, defense, biomedicine, robotics, chemicals and more.
nanoTX has established a reputation for delivering solid content, compelling panel discussions, early-stage investment opportunities and a world-class roster of presenters. This year’s signature Nobel Laureates Legends program sponsored by IEEE features a reunion of the original Nobel Prize-winning Buckyball discovery team – the breakthrough advancement that started the whole carbon nanotechnology and nanotube revolution we’re seeing today, and into tomorrow. For more information and to register, please visit www.nanotx.biz.
